This week, hosts Mark Masselli and Margaret Flinter speak with Edward Abrahams, President of the Personalized Medicine Coalition which supports the emerging science of precision medicine and the huge potential it holds for cost savings with pharmacogenomics, targeted therapies, and improved outcomes for patients and health systems. They discuss the Coalition's upcoming summit at Harvard which will bring together policy makers, leading scientists, advocates and provider organizations to devise strategies for advancing precision medicine.